Abbott reported new study findings supporting the use of its Tendyne transcatheter mitral valve replacement (TMVR) system.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback